Page 1928 - Cote clinical veterinary advisor dogs and cats 4th
P. 1928

Testicular Tumors   963


           Differential Diagnosis
           •  Testicular torsion
  VetBooks.ir  •  Cyst                                                                                                Diseases and   Disorders
           •  Abscess
           Initial Database
           •  CBC:  rule  out  bone  marrow  suppres-
             sion due  to Sertoli  cell tumor–associated
             hyperestrogenism.
           •  Semen evaluation and/or testicular biopsy
             with  histologic  exam  of  unaffected  testis
             can aid in decision for unilateral or bilateral
             castration in breeding dogs.       A                                 B
           Advanced or Confirmatory Testing    TESTICULAR TUMORS  A, Transscrotal ultrasonogram of left testis of a normal fertile male dog. Echotexture
           •  Ultrasound, all tumor types: hypoechoic or   of the parenchyma is homogeneous, with the exception of the hyperechoic mediastinum (rete testis; arrow). B,
             mixed echotexture                 Transscrotal ultrasonogram of left testis of an infertile male dog. Two anechoic cystic structures are seen within
           •  Cytologic evaluation of abnormal testis  the parenchyma on either side of the mediastinum. Differential diagnoses include cystic neoplasia or testicular
                                               cyst. (Courtesy Dr. Michelle A. Kutzler.)
           •  Gross pathologic exam of excised testis
             ○   Seminoma signs include soft to slightly
               firm  testis;  homogeneous,  gray/white,
               glistening appearance;  possible areas   Methotrexate,  vincristine,  and  cyclophos-   PEARLS & CONSIDERATIONS
               of discoloration due to hemorrhage or   phamide; cisplatin; bleomycin; and radiation
               necrosis; focal to multifocal   therapy have been reported to have some degree   Comments
             ○   Sertoli cell tumor signs include very firm   of efficacy.        •  Histopathologic exam is needed for deter-
               testis that are discrete, white or gray, with                        mination of tumor type.
               possible tan or yellow hemorrhagic areas;   Behavior/Exercise      •  Unilateral  castration  may  result  in  up  to
               usually focal                   Avoid  estrous  females,  and  restrict  physical   50%  compensatory  hypertrophy  of  the
             ○   Leydig cell tumor signs include soft testis   activity for approximately 1 week after surgery.  remaining testis. Return to fertility after
               that are discrete and yellow/brown, bulges                           unilateral castration depends on the severity
               on section, areas of hemorrhage or cystic   Possible Complications   of testicular atrophy secondary to hormonal
               change common, focal to multifocal  •  Bone marrow suppression (hyperestrogenism)   downregulation and presence of underlying
             ○   Mixed germ cell/stromal tumor signs   from Sertoli cell tumors     disease (testicular degeneration with loss of
               include various textures and pale white   •  Behavioral changes (hyperandrogenism) from   spermatogonia).
               or gray appearance; generally discrete and   Leydig cell tumors
               focal                                                              Prevention
           •  Bilateral tumors are common, and multiple   Recommended Monitoring  Testicular  removal,  especially  of  cryptorchid
             tumor types often occur in the same testis.  •  Seminoma,  Leydig  cell  tumor,  nonactive   testes
           •  Histopathologic exam: include spermatic cord   Sertoli cell tumor, mixed sex cord–stromal
             to evaluate for local invasion; multiple tumor   tumor: yearly physical exam  Technician Tips
             types can occur in the same testis.  •  Sertoli cell tumor with bone marrow suppres-  •  Make  a  longitudinal  incision  into  testes
                                                sion: close follow-up resolution of anemia,   greater than 2.5 cm in diameter to aid in
            TREATMENT                           thrombocytopenia, and leukopenia; yearly   fixation for histopathology submission.
                                                physical exam after marrow recovery  •  When  fixing,  use  an  adequate  amount  of
           Treatment Overview                                                       formalin (1 part tissue to 9 parts formalin).
           Therapy  consists  of  surgical  removal  of  the    PROGNOSIS & OUTCOME
           affected testis.                                                       Client Education
                                               •  Seminoma: excellent after testicular removal;   •  Regular exam of testes and evaluation of the
           Acute General Treatment              metastasis is rare.                 semen in breeding animals
           •  Testicular  removal:  castration;  unilateral   •  Sertoli cell tumor: excellent after testicular   •  Prompt presentation for veterinary exam if
             castration if contralateral testis is normal   removal;  metastasis  is  rare,  but  risk  of   an abnormality is detected
             to small and future breeding with the dog   metastasis is increased for tumors > 2 cm
             is desired                         diameter.                         SUGGESTED READING
           •  Supportive  care  for  dogs  with  Sertoli  cell   •  Leydig cell tumor: excellent after testicular   Agnew DW, et al: Tumors of the genital systems. In
             tumor–associated bone marrow suppression  removal; metastasis is not expected.  Meuten DJ, editor: Tumors in domestic animals, ed
                                               •  Mixed  sex  cord–stromal  tumor:  excellent    5, Ames, IA, 2017, Wiley Blackwell, pp 706-714.
           Chronic Treatment                    after testicular removal; metastasis is not
           For metastatic seminoma, both chemotherapy   expected.                 AUTHOR: Beth A. Valentine, DVM, PhD, DACVP
                                                                                  EDITOR: Michelle A. Kutzler, DVM, PhD, DACT
           and radiation therapy have been described.











                                                      www.ExpertConsult.com
   1923   1924   1925   1926   1927   1928   1929   1930   1931   1932   1933